Skip to main content
SpringerLink
Log in

Hormonale Kontrazeption

  • Chapter
Klinische Endokrinologie für Frauenärzte

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aktories K, Krög W, Dericks-Tan E, Jürgensen O, Taubert HD (1976) Die Beeinflussung des Ovarialzyklus durch verschiedene Typen hormonaler Kontrazeptiva. Geburtshilfe Frauenheilkd 36:318

    PubMed  Google Scholar 

  • Andersson K (2001) The levonorgestrel intrauterine system: more than a contraceptive. Eur J Contracept Reprod Health Care 6[Suppl 1]: 15

    PubMed  Google Scholar 

  • Andersson K, Odlind V, Rybo G (1994) Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 49: 56

    PubMed  Google Scholar 

  • Apter D, Borsos A, Baumgartner W et al. (2003) Effect off an oral contraception containing drospirenone and ethinyestradiol on general well-being and fluid-related symptoms. Eur J Contracept Reprod Health Care 8: 37

    PubMed  Google Scholar 

  • Archer DF (1994) Clinical and metabolic features of desogestrel: a new oral contraceptive preparation. Am J Obstet Gynecol 170:1550

    PubMed  Google Scholar 

  • Aufdemorte TB, Sheridan PJ (1981) Nuclear uptake of sex steroids in gingiva of the baboon. J Periodontol 52:430

    PubMed  Google Scholar 

  • Bäckström T (1983) Premenstrual tension syndrome. In: Bardin CW, Milgröm E, Mauvais-Jarvis P (eds) Progesteron and progestins. Raven, New York/NY, p 203

    Google Scholar 

  • Baldaszti E, Wimmer-Puchinger B, Loschke K (2003) Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception 67:87

    Article  PubMed  Google Scholar 

  • Boston Collaborative Drug Surveillance Programme (1973) Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Lancet 1:1399

    Google Scholar 

  • Bracken MB (1990) Oral contraception and congenital malformations in offspring: a review and metaanalysis of the prospective studies. Obstet Gynecol 76:552

    PubMed  Google Scholar 

  • Bracken MD, Hellenbrandt KG, Holford TR (1990) Contraception delay after oral contraceptive use: the effect of estrogen dose. Fertil Steril 53:21

    PubMed  Google Scholar 

  • Braendle W, Kleinkauf-Houcken A (1998) Hormonale Kontrazeption — aktueller Stand und Neuentwicklungen. Gynäkologe 31:417

    Google Scholar 

  • Breckwoldt M, Zahradnik HP (1987) Pathophysiologie der Dysmenorrhoe. In: Mall-Haefeli M (Hrsg) Wirkung kontrazeptiver Steroide. Ð, Ð S 7

    Google Scholar 

  • BZGA, Bundeszentrale für gesundheitliche Aufklärung (2001) Jugendsexualität. Wiederholungsbefragung bei 14-bis 17-Jährigen und ihren Eltern — Ergebnisse der repräsentativen Umfrage, S 47 http://www.bzga.de/bzga_stat/studienCachrimanidou AC, Hellberg D, Nilsson S et al. (1994) Hemostatis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive. Contraception (US) 50:153–165

    Google Scholar 

  • Cachrimanidou AC, Hellberg D, Nilsson S et al. (1994) Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive. Contraception 50:153

    Article  PubMed  Google Scholar 

  • Caroli-Bosc FX, Deveau C, Harris A et al. (1999) Prevalence of cholelithiasis: results of an epidemiologic investigation in Vidauban, southeast 255 France. General Practitioner’s Group of Vidauban. Dig Dis Sci 44: 1322

    Article  PubMed  Google Scholar 

  • Conell EB, Kelman CD (1968) Ophthalmologic findings with oral contraceptives. Obstet Gynecol 31:456

    PubMed  Google Scholar 

  • Coney P, Washenik K, Langley RG et al. (2001) Weight change and adverse event incidence with al low-dose oral contraceptive: two randomized, placebo-controlled trials. Contraception 63: 297

    Article  PubMed  Google Scholar 

  • Cramer DW, Goldman MB, Schiff I et al. (1987) The relationship of tubal infertility to barrier method and oral contraceptives use. JAMA 257: 2446

    Article  PubMed  Google Scholar 

  • Cuckle HS, Wald NJ (1982) Evidence against oral contraceptives as a cause of neural tube defects. Br J Obstet Gynaecol 89: 547

    PubMed  Google Scholar 

  • De Stefano F, Peterson HB, Ory HW, Layde PM (1982) Oral contraceptives and postoperative venous thrombosis. Am J Obstet Gynecol 143: 227

    PubMed  Google Scholar 

  • Dericks-Tan JSE, Schneider K, Taubert HD (1980) The mechanism of action of a new low-dosed combined oral contraceptive. Arch Gynäk 229: 107

    Google Scholar 

  • Dickerson V (2002) Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone. Reprod Med 47(Suppl 11): 985

    Google Scholar 

  • Ebeling K, Nischan P, Schindler C (1987) Use of oral contraceptives and risk of invasive cervical cancer in previously screened women. Int J Cancer 39:427

    PubMed  Google Scholar 

  • Endrikat J, Gerlinger C, Plettig K et al. (2003) A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive use. Gynecol Endocrinol 17:107

    PubMed  Google Scholar 

  • Eschenbach DA, Harnisch JP, Holmes KK (1977) Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors. Am J Obstet Gynecol 128: 838

    PubMed  Google Scholar 

  • Fasal E, Paffenbarger RS (1975) Oral contraceptives as related to cancer and benign lesions of the breast. J Natl Cancer Inst 55: 767

    PubMed  Google Scholar 

  • Fasoli M, Parazzini F, Cecchetti G, La Vecchia C (1989) Postcoital contraception: an overview of published studies. Contraception 39:459

    Article  PubMed  Google Scholar 

  • Fisch IR, Frank J (1977) Oral contraceptives and blood pressure. JAMA 237: 2499

    Article  PubMed  Google Scholar 

  • Franceschi S, La Vecchia C, Parazzini F et al. (1984) Oral contraceptives and benign breast disease: a case-control study. Am J Obstet Gynecol 149:602

    PubMed  Google Scholar 

  • Fraser IS, Jansen RPS (1983) Why do inadvertent pregnancies occur in oral contraceptive users. Contraception 27:531

    PubMed  Google Scholar 

  • Freeman EW (2002) Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder. Eur J Contracept Reprod Health 7 Suppl 3:27

    Google Scholar 

  • Frick V (1978) Störfaktor Sicherheit. Sexualmedizin 3: 221

    Google Scholar 

  • Gabius S, Blossey TH, Teichmann AT, Nagel GA (1988) Sind Östrogene beim Mammakarzinom kontraindiziert? DMW 45:1774

    Google Scholar 

  • Gaspard UJ, Dubois M, Gillain D et al. (1984) Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel. Contraception 29:305

    Article  PubMed  Google Scholar 

  • Gerstman BB, Piper JM, Tomita DK, Ferguson WJ (1991) Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am J Epidemiol 133:32

    PubMed  Google Scholar 

  • Glacet-Bernard A, Kuhn D, Soubrane G (1999) Ocular complications of hormonal treatments: oral contraception and menopausal hormonal replacement therapy. Contracep Fertil Sex 27: 285

    Google Scholar 

  • Godsland IF, Winkler UH, Lidegaard O, Crook D (2000) Occlusive vascular diseases: epidemiology, pathology and mechanisms. Drug 60: 721

    Google Scholar 

  • Göttlicher S, Madjaric J (1981) Neue Ergebnisse zur Frage eines Zusammenhangs zwischen oraler Kontrazeption und vaginalem Sproßpilzbefall. Geburtshilfe Frauenheilkd 41:630

    PubMed  Google Scholar 

  • Goldhaber SZ, Grodstein F, Stampfer MJ et al. (1997) A prospective study of risk factors for pulmonary embolism in women. JAMA 277:1933

    Article  Google Scholar 

  • Grady-Weliky TA (2003) Clinical practice. Premenstrual dysphoric disorder. N Engl J Med 348:433

    Article  PubMed  Google Scholar 

  • Graf M, Krussel JS, Conrad M et al. (1995) Regression of functional cysts: high dosage ovulation inhibitor and gestagen therapy has no added effect. Geburtshilfe Frauenheilkd 55: 387

    PubMed  Google Scholar 

  • Gray RH (1985) Reduced risk of pelvic inflammatory disease with injectable contraceptives. Lancet 1:1046

    Article  Google Scholar 

  • Guillebaud J (1983) The 150/30 Formulation. Experience in the United Kingdom. J Reprod Med 28[Suppl]: 66

    PubMed  Google Scholar 

  • Hammerstein J (1984) Grundsätzliche Betrachtung zur Wahl der Methode bei Mann und Frau. Gynäkologe 17:156

    PubMed  Google Scholar 

  • Harlap S, Shiono PH, Ramcharan S (1985) Congenital abnormalities in the offspring of women who used oral and other contraceptives around the time of conception. Int J Fertil 30:39

    PubMed  Google Scholar 

  • Heinemann LA, Weimann A, Gerken G et al. (1998) Modern oral contraceptive use and benign liver tumors. The German Benign Liver Tumor Case-Control-Study. Eur J Contracept Reprod Health Care 3:194

    PubMed  Google Scholar 

  • Hertzen von H, Piaggio C, Ding J et al. (2002) Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 360:1803

    Article  PubMed  Google Scholar 

  • Hidalgo M, Bahamondes L, Perrotti M et al. (2002) Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 65:129

    Article  PubMed  Google Scholar 

  • Hislop TG, Threlfall WJ (1984) Oral contraceptives and benign breast disease. Am J Epidemiol 120: 273

    PubMed  Google Scholar 

  • Hofmann AD (1984a) Contraception in adolescence: A review. 1. Psychosocial aspects. Bulletin of the World Health Organization 62:151

    PubMed  Google Scholar 

  • Hofmann AD (1984b) Contraception in adolescene: a review. 2. Biomedical aspects. Bulletin of the World Health Organization 62:331

    PubMed  Google Scholar 

  • Huggins GR, Zucker PK (1987) Oral contraceptives and neoplasia: 1987 update. Fertil Steril 47: 733

    PubMed  Google Scholar 

  • Ippen H, Tesche S (1972) Das «Chloasma“ außerhalb der Gravidität. Hautarzt 23: 21

    PubMed  Google Scholar 

  • Jain AK (1976) Cigarette smoking, use of oral contraceptives and myocardial infarction. Am J Obstet Gynecol 126: 301

    PubMed  Google Scholar 

  • Jick H, Kaye JA, Vasilakis-Scaramozza C, Jick SS (2000) Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis. BMJ 321: 1190

    Article  PubMed  Google Scholar 

  • Kaiser R, Kloppenburg W, Ehmke H, Schwenk H (1987) Menstruationszyklus nach hormonaler Wachstumshemmung bei Mädchen. Geburtshilfe Frauenheilkd 47:410

    PubMed  Google Scholar 

  • Kasan PN, Andrews J (1980) Oral contraception and congenital abnormalities. Br J Obstet Gynaecol 87: 545

    PubMed  Google Scholar 

  • Keller PJ (1986) Chemie und Pharmakologie der synthetischen Gestagene. Endokrinologisches Arbeitstreffen «Kontrazeptive Gestagene». Thieme, Stuttgart New York, S 3

    Google Scholar 

  • Killick S (2002) Complete and robust ovulation inhibition with NuvaRing. Eur J Contracep Reprod Health Care [Suppl 2]: 13; disc 37

    Google Scholar 

  • Kjos SL, Peters RK, Xiang A et al. (1998) Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. JAMA 280:533

    Article  PubMed  Google Scholar 

  • Klinger G, Eick S, Klinger G et al. (1998) Influence of hormonal contraceptives of microbial flora of gingival sulcus. Contraception 57:381

    Article  PubMed  Google Scholar 

  • Kornman KS, Loesche WJ (1979) The subgingival microbial flora during pregnancy. J Periodontal Research 15:111

    Google Scholar 

  • Kreek MJ, Sleisenger MH, Jeffries GH (1967) Recurrent cholestatic jaundice of pregnancy with demonstrated estrogen sensitivity. Am J Med 43: 795

    Article  PubMed  Google Scholar 

  • Kwiecien M, Edelman A, Nichols MD, Jensen JT (2003) Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception 67:9

    Article  PubMed  Google Scholar 

  • Lauritzen C (1987) Hormonale Kontrazeption. Adam Pharma, Essen

    Google Scholar 

  • La Vecchia C, Franceschi S, Decarli A (1984) Oral contraceptive use and the risk of epithelial ovarian cancer. Br J Cancer 50: 31

    PubMed  Google Scholar 

  • Lidegaard O (1998) The thrombotic diseases in young women and the influence from oral contraceptives. Am J Obstet Gynecol 179: 62

    Article  PubMed  Google Scholar 

  • Louv WC, Austin H, Perlman J, Alexander WJ (1989) Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol 160:396

    PubMed  Google Scholar 

  • Lundström V, af Geijerstam G (1983) Treatment of primary dysmenorrhea. Acta Obstet Gynecol Scand [Suppl] 113: 83

    Google Scholar 

  • Mansour D (2002) Experiences with Yasmin: the acceptability of a novel contraception and its effect on well-being. Eur J Contracet Reprod Health Care 7,Suppl 3:35, disc 42–43

    Google Scholar 

  • Martinelli I, Sacchi E, Landi G et al. (1998) High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 338:1793

    Article  PubMed  Google Scholar 

  • Martinelli I, Taioli E, Bucciarelli P et al. (1999) Interaction between the G20210 A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis. Arterioscler Thromb Vasc Biol 19: 700

    PubMed  Google Scholar 

  • Mason B, Oakley N, Wynn V (1973) Studies of carbohydrate and lipid metabolism in women developing hypertension on oral contraceptives. Br Med J III: 317

    Google Scholar 

  • Milne R, Vessey M (1991) The association of oral contraception with kidney cancer, colon cancer, gallbladder cancer (including extrahepatic bile duct cancer) and pituitary tumors. Contraception 6: 667

    Article  Google Scholar 

  • Milsom I, Andersch B (1984) Effect of various oral contraceptive combinations on dysmenorrhea. Gynecol Obstet Invest 17:284

    PubMed  Google Scholar 

  • Mishell DR (1982) Noncontraceptive health benefits of oral steroidal contraceptives. Am J Obstet Gynecol 142:809

    PubMed  Google Scholar 

  • Molina R, Thomas DB, Dabancens A et al. (1988) Oral contraceptives and cervical carcinoma in situ in Chile. Cancer Res 48:1011

    PubMed  Google Scholar 

  • Narod SA, Dube MP, Klijn J et al. (2002) Oral contraceptives and the rrisk of breast cancer BRCA1 and BRCA2 mutation carries. J Natl Cancer Inst 94:1773

    PubMed  Google Scholar 

  • Nilsson CG, Lähteenmäki P (1977) Recovery of ovarian function after the use of a d-norgestrel-releasing IUD. Contraception 15:389

    Article  PubMed  Google Scholar 

  • Oelkers W (2000) Drospirenone — a new progestogen with antimineralocorticoid activity resembling natural progesterone. Eur J Contracep Reprod Health Care [Suppl 3]: 17

    Google Scholar 

  • Oelkers W, Helmerhorst FM, Wuttke W, Heithecker R (2000) Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers. Gynecol Endocrinol 14:204

    PubMed  Google Scholar 

  • Pain JA, Gimson AES, Williams R, Howard ER (1991) Focal nodular hyperplasia of the liver: results of treatment and options of management. GUT 32:524

    PubMed  Google Scholar 

  • Pearl R (1932) Contraception and fertility in 2000 women. Human Biology 4:363

    Google Scholar 

  • Petersen KR, Skouby SO, Jespersen J (1996) Contraception guidance in women with pre-existing disturbances in carbohydrate metabolism. Eur J Contracep Reprod Health Care 1: 53

    Google Scholar 

  • Petersen P (1978) Seelische Veränderungen bei hormonaler Kontrazeption der Frau. Dtsch Arztebl 18:1075

    Google Scholar 

  • Petitti DB, Wingerd J, Pellegrin F, Ramcharan S (1979) Risk of vascular disease in women. JAMA 242:1150

    Article  PubMed  Google Scholar 

  • Pituitary Adenoma Study Group (1983) Pituitary adenomas and oral contraceptives: A multicenter case control study. Fertil Steril 39: 753

    Google Scholar 

  • Podoshin L, Gertner R, Fradis M et al. (1978) Oral contraceptives pills and clinical otosclerosis. Int J Gynaecol Obstet 15:554

    PubMed  Google Scholar 

  • Poettgen H (1989) Wenn ich Jugendlichen die Pille verordnen soll. Sexualmedizin 6: 310

    Google Scholar 

  • Rabe T (2001) Kontrazeption — heutiger Stand und Zukunftsperspektiven. In: Rabe T, Strowitzki T (Hrsg) Life style und Anti-Aging Medizin. Rendezvous, Baden-Baden, S 2001

    Google Scholar 

  • Rabe T, Runnebaum B (1982) Kontrazeption. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Rabe T, Grundwald K, Runnebaum B (1988) Pille und Kohlenhydratstoffw echsel. Fertilität 4:97

    Google Scholar 

  • Ragan RE, Rock RW, Buck HW (2003) Metoclopramide pretreatment attenuates emergency contraceptive-associated nausea. Am J Obstet Gynecol 188:330

    Article  PubMed  Google Scholar 

  • Rahn KH (1984) Äußerungen von Schäden an der Haut. In: Rahn KH (Hrsg) Erkrankungen durch Arzneimittel. Thieme, Stuttgart New York

    Google Scholar 

  • Rechenberger I (1989) Psychosomatische Aspekte des prämenstruellen Syndroms. Gynäkologe 22:332

    PubMed  Google Scholar 

  • Ronnerdag M, Odlind V(1999) Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand 78: 716

    Article  PubMed  Google Scholar 

  • Rooks JB, Ory HW, Ishak K et al. (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. J Am Med Ass 242:644

    Article  Google Scholar 

  • Rosenberg L (1991) The risk of liver neoplasia in relation to combined oral contraceptive use. Contraception 43:643

    Article  PubMed  Google Scholar 

  • Rosenberg L, Kaufman DW, Helmrich SP et al. (1985a) Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA 253: 2965

    Article  PubMed  Google Scholar 

  • Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S (1985b) The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 313:1511

    PubMed  Google Scholar 

  • Rosenberg L, Palmer JR, Lesko SM, Shapiro S (1990) Oral contraception use and the risk of myocardial infarction. Am J Epidemiol 131:1009

    PubMed  Google Scholar 

  • Rosenberg M, Waugh MS (1999) Causes and consequences of oral contraceptive noncompliance. Am J Obstet Gynecol 180: 276

    Google Scholar 

  • Rosenberg L, Palmer JR, Rao RS, Shapiro S (2001) Low-dose oral contraceptive use and the risk of myocardial infarction. Arch Intern Med 161:1065

    Article  PubMed  Google Scholar 

  • Royal College of General Practitioners (1974) Oral contraceptives and health; an interim report from the oral contraception study of the Royal College of General Practitioners. Pitman, New York

    Google Scholar 

  • Runnebaum B, Rabe T (1987) New progestogens in oral contraceptives. Am J Obstet Gynecol 157:1059

    PubMed  Google Scholar 

  • Rydén G, Fahraeus L, Molin L, Ahman K (1979) Do contraceptives influence the incidence of acute pelvic inflammatory diseases in women with gonorrhea? Contraception 20:149

    Article  PubMed  Google Scholar 

  • Samani F, Bolzonello P, Fior R, Elia A (1987) Effects on hearing during prolonged oral contraceptive use. Contraception 35:41

    Article  PubMed  Google Scholar 

  • Schindler AE (1984) Hormonale postkoitale Kontrazeption. Frauenarzt 2: 47

    Google Scholar 

  • Scholten PC, van Eykeren MA, Christiaens GCML, Haspels AA (1989) Menstrual blood loss with levonorgestrel Nova-T and multiload CU 250 intrauterine devices. In: Scholten PC. The levonorgestrel IUD — clinical performance and impact on menstruation. Habilitation Universiteit Utrecht, The Netherlands, p 35

    Google Scholar 

  • Schützel H, Neumann F (1988) Potential risk of intrauterine feminization in man from the antiandrogen cyproterone acetate (CPA) in recommended dose regimens. In: XII World Congress of Gynecology and Obstetrics, Rio de Janeiro, Abstraktbd, p 703

    Google Scholar 

  • Schwartz U (1986) Kontrazeption in der Prämenopause. Gynäkologe 19: 254

    PubMed  Google Scholar 

  • Scott LD, Katz AR, Duke JH et al. (1984) Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver. JAMA 251: 1461

    Article  PubMed  Google Scholar 

  • Seed M, Godsland IF, Wynn V, Jacobs HS (1984) The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism. Clin Endocrinology 21:689

    Google Scholar 

  • Shaffer EA, Taylor PJ, Logan K et al. (1984) The effect of a progestin on gall-bladder function in young women. Am J Obstet Gynecol 148: 504

    PubMed  Google Scholar 

  • Sillem M, Teichmann AT(1994) The liver. In:Goldzieher J(ed) Pharmacology of the contraceptive steroids. Raven, New York

    Google Scholar 

  • Sivin I (2003) Risk and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants. Drug Saf 26: 303

    PubMed  Google Scholar 

  • Skouby SO (1988) Oral contraceptives: effects on glucose and lipid metabolism in insulin-dependent diabetic women and women with previous gestational diabetes. Danish Med Bulletin 35:157

    Google Scholar 

  • Smith JS, Green J, Berrington de Gonzales A et al. (2003) Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 361: 1159

    Article  PubMed  Google Scholar 

  • Sooriyamoorthy M, Gower DB (1989) Hormonal influences on gingival tissue: relationship to periodontal disease. J Clin Periodontol 16: 201 257

    PubMed  Google Scholar 

  • Spitzer WO, Lewis MA, Heinemann LA et al. (1996) Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational research group on oral contraceptives an the health of young women. BMJ 312: 83

    PubMed  Google Scholar 

  • Spycher C, Bigler G (2001) Postcoital emergency contraception. Ther Umsch 58: 541

    PubMed  Google Scholar 

  • Stamm H, Kraus J (1977) Pharmakotherapeutische Grundlagen der hormonellen Kontrazeption. Mod Arzneimittel Ther 1/4: 243

    Google Scholar 

  • Stéphan F, Réville P (1977) Diabetes und Östrogene-Gestagene. Münch Med Wochenschr 119: 663

    Google Scholar 

  • Sulak PJ, Cressman BE, Waldrop E et al. (1997) Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol 89:179

    Article  PubMed  Google Scholar 

  • Svensson L, Weström L, Mardh PA (1984) Contraceptives and acute salpingitis. JAMA 251: 2553

    Article  PubMed  Google Scholar 

  • Szarewski A (2002) High acceptability and satisfaction with NuvaRing use. Eur J Contracep Reprod Health Care Supp2: 31, disc37

    Google Scholar 

  • Tanis BC, van den Bosch MA, Kemmeren JM et al. (2001) Oral contraceptives and the risk of myocardial infarction. N Engl J Med 345:1787

    Article  PubMed  Google Scholar 

  • Tankeyoon M, Dusitsin N, Chalapati S (1984) Effects of hormonal contraceptives on milk volume and infant growth. Contraception 30:505

    Article  PubMed  Google Scholar 

  • Taubert HD, Kuhl H (1995) Kontrazeption mit Hormonen. Thieme, Stuttgart New York, S 172

    Google Scholar 

  • Teichmann AT(1996) Empfängnisverhütung. Thieme, Stuttgart New York

    Google Scholar 

  • Teichmann AT (2002) Hormonale Kontrazeption. Gynäkologe 35:263

    Google Scholar 

  • The Centers for Disease Control Cancer and Steroid Hormone Study (1983a) Oral contraceptive use and the risk of ovarian cancer. JAMA 249:1596

    Google Scholar 

  • The Centers for Disease Control Cancer and Steroid Hormone Study (1983b) Oral contraceptive use and the risk of endometrial cancer. JAMA 249: 1600

    Google Scholar 

  • Ursin G, Peter RK, Henderson BE et al. (1994) Oral contraceptive use and adenocarcinoma of cervix. Lancet 344:1390

    Article  PubMed  Google Scholar 

  • Varila E, Wahlstrom T, Rauramo I (2001) A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy. Fertil Steril 76:969

    Article  PubMed  Google Scholar 

  • Vessey MP, Metcalfe A, Wells C, McPherson K, Westhoff C, Yeates D (1987) Ovarian neoplasms, functional ovarian cysts, and oral contraceptives. Br Med J 294:1518

    Google Scholar 

  • Vessey M, Painter R (2001) Oral contraception and ear disease: findings in a large cohort study. Contraception 63:61

    Article  PubMed  Google Scholar 

  • Villiers de EM (2003) Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer 103:705

    Article  PubMed  Google Scholar 

  • Washington AE, Gove S, Schachter J et al. (1985) Oral contraceptives, chlamydia trachomatis infection, and pelvic inflammatory disease. JAMA 253: 2246

    Article  PubMed  Google Scholar 

  • Weir RJ, Davies DL, Fraser R, Morton JJ, Tree M, Wilson A (1975) Contraceptive steroids and hypertension. J Steroid Biochem 6:961

    Article  PubMed  Google Scholar 

  • Weisberg E (1982) Fertility after discontinuation of oral contraceptives. Clin Reprod Fertil 1:261

    PubMed  Google Scholar 

  • Wenderlein JM (1981) Keine Häufung von Depressionen unter hormonaler Kontrazeption. Med Klin 76: 288

    PubMed  Google Scholar 

  • WHO, World Health Organization (1995a) Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 346:1582

    Google Scholar 

  • WHO, World Health Organization (1995b) Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case control study. Lancet 346:1575

    Google Scholar 

  • WHO Task Force on post-ovulatory methods of fertility regulation (1998) Randomized controlled trial of levonorgestrel the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 352:428

    Google Scholar 

  • WHO Technical Report (1998) Report of a WHO-Scientific group: cardio-vascular disease and steroid hormone contraception. Genf/Schweiz, Series 877

    Google Scholar 

  • Wiebe RH, Morris CV (1984) Effect of an oral contraceptive on adrenal and ovarian androgenic steroids. Obstet Gynecol 63:12

    PubMed  Google Scholar 

  • Winkler UH, Schindler AE, Endrikat J, Düsterberg B (1996) A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 µg and 30 µg ethinyle-stradiol. Contraception 53: 75

    Article  PubMed  Google Scholar 

  • Woods JW (1988) Oral contraceptives and hypertension. Hypertension 11[Suppl II]: 11

    Google Scholar 

  • Woutersz TB (1983) A new ultra-low-dose combination oral contraceptive. J Reprod Med 28: [Suppl] 81

    PubMed  Google Scholar 

  • Wynn V, Godsland I (1986) Effects of oral contraceptives on carbohydrate metabolism. J Reprod Med 31: 892

    PubMed  Google Scholar 

  • Xiao BL, Hertzen von H, Zhao H, Piaggio G (2002) A randomized double-blind comparison of two single doses of mifepristone for emergency contraception. Hum Reprod 17: 3084

    Article  PubMed  Google Scholar 

  • Yuzpe A, Smith RP, Rademaker AW (1982) A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as a postcoital contraceptive agent. Fertil Steril 37: 508

    PubMed  Google Scholar 

  • Zaun H (1980) Orale Kontrazeptiva und Hautveränderungen. Dtsch Arztebl 77: 2347

    Google Scholar 

  • Zaun H (1982) Dermatotrope Wirkungen hormonaler Kontrazeptiva. In: Kaiser R (Hrsg) Hormonale Kontrazeption — aktuelle medizinische und juristische Aspekte. Schering, Berlin, S 15

    Google Scholar 

  • Zimmermann T, Dietrich H, Wisser KH, Münch C (1999) Fertility after discontinuation of the Dienogest-containing oral contraceptive Valette. First data of an ongoing study. Drugs Today Suppl C 35: 89

    Google Scholar 

Download references

Authors
  1. U. Winkler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lokstedter Damm 15, 22453, Hamburg

    Freimut Leidenberger

  2. Abt. Gynäkologische Endokrinologie und Fertilitätsstörungen, Universitätsfrauenklinik Heidelberg, Voßstraße 9, 69115, Heidelberg

    Thomas Strowitzki

  3. Klinik für Frauenheilkunde und Geburtshilfe der Universität Regensburg am Caritas Krankenhaus St. Josef, Landshuter Straße 65, 93053, Regensburg

    Olaf Ortmann

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Winkler, U. (2005). Hormonale Kontrazeption. In: Leidenberger, F., Strowitzki, T., Ortmann, O. (eds) Klinische Endokrinologie für Frauenärzte. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26406-X_11

Download citation

  • DOI: https://doi.org/10.1007/3-540-26406-X_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-44162-5

  • Online ISBN: 978-3-540-26406-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation